logo

For the Inventor, By the Inventor

Freiburg, Germany

Christoph Schachtele

USPTO Granted Patents = 13


Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 176(Granted Patents)


Company Filing History:

goldMedal8 out of 18 
 
Goedecke Aktiengesellschaft
 patents
silverMedal4 out of 23 
 
Godecke Aktiengesellschaft
 patents
bronzeMedal1 out of 1 
 
Proqinase Gmbh
 patent

Years Active: 1989-2018

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 9925193 - Thioether derivatives as protein kinase inhibitors (2018-03-27),
2. 5945440 - Indolocarbazole imides and the use thereof (1999-08-31),
3. 5883114 - Indolocarbazole imides and the use thereof (1999-03-16),
4. 5750555 - Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino (1998-05-12),
5. 5516915 - Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the (1996-05-14),
6. 5489608 - Indolocarbazole derivatives and the use thereof (1996-02-06),
7. 5438050 - Indolocarbazole derivatives, processes for their preparation and (1995-08-01),
8. 5401875 - 2-aminocarboxylic acids and their derivatives, processes for their (1995-03-28),
9. 5380746 - Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the (1995-01-10),
10. 5322844 - Alkoxy-4 (1H)-pyridone derivatives, processes for the preparation (1994-06-21),
11. 5043335 - Indolocarbazoles and the use thereof (1991-08-27),
12. 4912107 - Pyrrolocarbazole derivatives, compositions containing them, and methods (1990-03-27),
13. 4855489 - 2-acyloxypropylamino derivatives, processes for the preparation thereof, (1989-08-08),

Title: Christoph Schachtele: Innovator in Pharmaceutical Chemistry

Introduction

Christoph Schachtele is a prominent inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases, including cancer. With a total of 13 patents, Schachtele's work has the potential to impact the treatment of serious health conditions.

Latest Patents

One of Schachtele's latest patents is focused on thioether derivatives as protein kinase inhibitors. This invention relates to thioether derivatives that are useful for the treatment, relief, and prevention of diseases associated with abnormal and hyperproliferation of cells in mammals, especially humans. These compounds are particularly beneficial for the treatment of all forms of cancer.

Another notable patent involves indolocarbazole imides and their use in pharmaceutical compositions. This invention addresses the preparation of compositions for the treatment and prevention of various diseases, including cancer, viral diseases such as HIV infections, heart and blood vessel diseases, and degenerative diseases of the central nervous system, among others. The compounds developed under this patent also serve as immune suppressives.

Career Highlights

Throughout his career, Christoph Schachtele has worked with reputable companies, including Goedecke Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Schachtele has collaborated with notable colleagues, including Claus Rudolph and Johannes Hartenstein. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Christoph Schachtele's innovative work in pharmaceutical chemistry has led to the development of important compounds that address critical health issues. His contributions, reflected in his 13 patents, continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…